(Q37942219)

25 August 2017

1 reference

title

Treatment of dementia with Lewy bodies and Parkinson's disease dementia (English)

1 reference

dementia with Lewy bodies

25 August 2017

0 references

1 reference

1 reference

1

Clive Ballard

1 reference

25 August 2017

Zunera Kahn

2

1 reference

PubMed ID

21970305

25 August 2017

Anne Corbett

series ordinal

3

1 reference

25 August 2017

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

28

1 reference

25 August 2017

10

1 reference

25 August 2017

769-777

1 reference

https://scigraph.springernature.com/pub.10.2165/11594110-000000000-00000

25 August 2017

0 references

cites work

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Quetiapine for agitation or psychosis in patients with dementia and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Dementia with Lewy bodies: response of delirium-like features to donepezil.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Cardiovascular effects of donepezil in patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Neuroleptic drugs in dementia: benefits and harm

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Old and ill and still feeling well? Determinants of subjective well-being in >or=60 year olds: the role of the sense of coherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Behavioral treatment of depression in dementia patients: a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

The role of levodopa in the management of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

CSF α-synuclein as a diagnostic biomarker for Parkinson disease and related dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594110-000000000-00000

21 January 2018

Memantine for dementia

1 reference

12 December 2020

Coma with accidental single dose of an atypical neuroleptic in a patient with Lewy Body dementia

1 reference

12 December 2020

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials

1 reference

12 December 2020

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias

1 reference

12 December 2020

Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients

1 reference

12 December 2020

Cholinesterase inhibition in Parkinson's disease

1 reference

12 December 2020

Antidepressants for treating depression in dementia

1 reference

12 December 2020

Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease.

1 reference

12 December 2020

Donepezil for dementia with Lewy bodies: a case study

1 reference

12 December 2020

10.2165/11594110-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

21970305

Dimensions Publication ID

25 August 2017

0 references

1 reference

PubMed ID

21970305